Загрузка...
Emerging disease‐modifying strategies targeting α‐synuclein for the treatment of Parkinson's disease
Parkinson's disease is the most common neurodegenerative movement disorder. It arises as a result of neuronal cell death in specific brain regions, notably the substantia nigra pars compacta, and is characterized by the accumulation of α‐synuclein in these brain regions. Current pharmacological...
Сохранить в:
| Опубликовано в: : | Br J Pharmacol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6031880/ https://ncbi.nlm.nih.gov/pubmed/29722028 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14345 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|